{"id":"https://genegraph.clinicalgenome.org/r/15f4fa72-19a6-480f-bf50-158a42f64a9av1.1","type":"EvidenceStrengthAssertion","dc:description":"SAMD9L was first reported in relation to autosomal dominant SAMD9L-related spectrum and myeloid neoplasm risk in 2016 (Chen et al., PMID: 27259050). SAMD9L-related spectrum and myeloid neoplasm risk was originally reported in 1978 by Li et al., PMID: 283689. Clinical manifestation is characterized by variable presentations of ataxia and cytopenia, myelodysplastic syndrome (MDS), monosomy 7, acute myelogenous leukemia (AML), and bone marrow failure (BMF). The spectrum can include manifestations in multiple organ systems, particularly neurologic, dermatologic and immunologic, with immune deficiency and/or systemic inflammation. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanisms, inheritance pattern, or phenotypic variability. Therefore, the following disease entities have been lumped into one disease entity: ataxia-pancytopenia syndrome (OMIM:159550), monosomy 7 myelodysplasia and leukemia syndrome 1 (OMIM:252270), and spinocerebellar ataxia 49 (OMIM:619806). Twenty-seven variants (missense and frameshift) that have been reported in twenty-seven probands in seven publications (PMIDs: 27259050, 28202457, 29146900, 30322869, 34621053, 35310830, 37216690) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be gain of function for onset in childhood, loss of function for onset in adulthood (PMID: 30322869). This gene-disease relationship is also supported by heterozygous and homozygous knockout mice phenocopying human disease as well as expression in child cerebellum as well as embryonic cerebellum and spinal cord tissues (PMIDs: 24029230, 35310830). In summary, there is definitive evidence supporting the relationship between SAMD9L and autosomal dominant SAMD9L-related spectrum and myeloid neoplasm risk. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Childhood, Adolescent, and Young Adult Cancer Predisposition GCEP on the meeting date January 14, 2025 (SOP Version 11). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/15f4fa72-19a6-480f-bf50-158a42f64a9a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/1b553726-ca22-4116-bb50-373089ac4cb6","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/1b553726-ca22-4116-bb50-373089ac4cb6_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10157","date":"2025-07-18T17:01:16.941Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/1b553726-ca22-4116-bb50-373089ac4cb6_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10157","date":"2025-01-14T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b553726-ca22-4116-bb50-373089ac4cb6_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6b41a19-d915-4b23-83c0-d51130252b52","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6b41a19-d915-4b23-83c0-d51130252b52_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29146900","allele":{"id":"https://genegraph.clinicalgenome.org/r/b264a260-591e-49b1-8c64-70c6430e1ae2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.3842G>A (p.Arg1281Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368179643"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a6b41a19-d915-4b23-83c0-d51130252b52_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"EdU incorporation assay showed that GOF SAMD9L variants inhibit cells from progressing through the cell cycle as depicted by the relative absence of cells in S-phase","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/153b43b1-c32a-4757-be67-5d6d6abbafeb","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/153b43b1-c32a-4757-be67-5d6d6abbafeb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37216690","allele":{"id":"https://genegraph.clinicalgenome.org/r/875159ec-d7d7-4114-8e35-e45128e35bbf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.3368T>C (p.Leu1123Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368183074"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/659b4243-290f-4454-a67c-5aba0bc5b405","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/659b4243-290f-4454-a67c-5aba0bc5b405_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34621053","allele":{"id":"https://genegraph.clinicalgenome.org/r/3de68b04-ec34-473d-a94b-67fc15205da9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.1993A>C (p.Thr665Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368193686"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/659b4243-290f-4454-a67c-5aba0bc5b405_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Growth inhibition of HEK293 cells upon overexpression of SAMD9L variant constructs","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2904e240-e5a9-45a7-bcbe-173c937e2ae5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2904e240-e5a9-45a7-bcbe-173c937e2ae5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34621053","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ae43bbb-1352-4ed7-be20-46da26d47e80","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.4420A>C (p.Thr1474Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368173801"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/2904e240-e5a9-45a7-bcbe-173c937e2ae5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Growth inhibition of HEK293 cells upon overexpression of SAMD9L variant constructs","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b0151e5e-3a7a-4317-a3f7-9cfa47ada1f2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0151e5e-3a7a-4317-a3f7-9cfa47ada1f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27259050","allele":{"id":"https://genegraph.clinicalgenome.org/r/478c64a5-e5bb-46ba-9004-daeec13bb816","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.3587G>C (p.Cys1196Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10583999"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6d305cec-7a37-442b-aa67-1b3b93172d75","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d305cec-7a37-442b-aa67-1b3b93172d75_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30322869","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8e2aa09-87a0-46c1-b56e-4613a87e1a9f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.3968del (p.Leu1323ProfsTer10)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2683737204"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/6d305cec-7a37-442b-aa67-1b3b93172d75_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant had a higher proliferation rate than WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1b553726-ca22-4116-bb50-373089ac4cb6_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea80389a-f0cb-4a08-b6b2-f52bba0519b4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35310830","rdfs:label":"Corral-Juan family","family":{"id":"https://genegraph.clinicalgenome.org/r/ea80389a-f0cb-4a08-b6b2-f52bba0519b4","type":"Family","rdfs:label":"Corral-Juan family","member":{"id":"https://genegraph.clinicalgenome.org/r/aab24762-8ec4-4690-b836-947eae64508f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35310830","rdfs:label":"Corral-Juan proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":68,"allele":{"id":"https://genegraph.clinicalgenome.org/r/09d60795-9fd4-41ab-b49c-e107f7f83386","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.1977C>T (p.Leu659=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA456628966"}},"firstTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f558ad3c-e9bb-4c7e-9781-faf6cb3455de_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35310830","allele":{"id":"https://genegraph.clinicalgenome.org/r/09d60795-9fd4-41ab-b49c-e107f7f83386"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"proband":{"id":"https://genegraph.clinicalgenome.org/r/aab24762-8ec4-4690-b836-947eae64508f"},"publishedLodScore":3.43,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8dfd8406-4da8-4c7d-bdca-d179462076bb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8dfd8406-4da8-4c7d-bdca-d179462076bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34621053","allele":{"id":"https://genegraph.clinicalgenome.org/r/f69322e8-156a-4df1-a615-41a05118e2d3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.3346A>C (p.Asn1116His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368183265"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/8dfd8406-4da8-4c7d-bdca-d179462076bb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Growth inhibition of HEK293 cells upon overexpression of SAMD9L variant constructs","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c30b0a1d-fbc5-4b43-9220-3c536b87377a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c30b0a1d-fbc5-4b43-9220-3c536b87377a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27259050","allele":{"id":"https://genegraph.clinicalgenome.org/r/40eafa53-6fd1-4f3d-96da-783af5e2428a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.2640C>A (p.His880Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10583998"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f558ad3c-e9bb-4c7e-9781-faf6cb3455de","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f558ad3c-e9bb-4c7e-9781-faf6cb3455de_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/f558ad3c-e9bb-4c7e-9781-faf6cb3455de_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patients’ fibroblasts had a lower level of SAMD9L protein than controls compared by qRT-PCR","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4370209a-738b-4e6f-8fc8-ea4e82398e31","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4370209a-738b-4e6f-8fc8-ea4e82398e31_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34621053","allele":{"id":"https://genegraph.clinicalgenome.org/r/7cebffd0-98ee-454d-a8db-e6423ce0df39","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.4046C>T (p.Pro1349Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368177811"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/4370209a-738b-4e6f-8fc8-ea4e82398e31_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Growth inhibition of HEK293 cells upon overexpression of SAMD9L variant constructs","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/37576fce-9f98-484f-81e8-25a03c4460ec","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37576fce-9f98-484f-81e8-25a03c4460ec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30322869","allele":{"id":"https://genegraph.clinicalgenome.org/r/1423c72b-712a-415e-92f8-6d6c6be61472","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.659A>G (p.Glu220Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4343838"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/37576fce-9f98-484f-81e8-25a03c4460ec_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant had a higher proliferation rate than WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f9230315-2189-419f-8177-ee3a8b03c75b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9230315-2189-419f-8177-ee3a8b03c75b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30322869","allele":{"id":"https://genegraph.clinicalgenome.org/r/ec0cac76-8a42-46f8-a9bb-032032ceae5a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.3892C>G (p.Arg1298Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4343388"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c00f8517-37e9-4cab-a662-cced1e3eaa47","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c00f8517-37e9-4cab-a662-cced1e3eaa47_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28202457","allele":{"id":"https://genegraph.clinicalgenome.org/r/231c86f2-01c3-4c0c-8c74-18a5d7ef3e49","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.2672T>C (p.Ile891Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368186665"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c00f8517-37e9-4cab-a662-cced1e3eaa47_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant had a higher proliferation rate than WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c1e25ad7-4ed3-4156-8373-1cd6d2707bcc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c1e25ad7-4ed3-4156-8373-1cd6d2707bcc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29146900","allele":{"id":"https://genegraph.clinicalgenome.org/r/34a4bf30-774b-47e8-ad69-b2916d60687f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.1877C>T (p.Ser626Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368194207"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c1e25ad7-4ed3-4156-8373-1cd6d2707bcc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"EdU incorporation assay showed that GOF SAMD9L variants inhibit cells from progressing through the cell cycle as depicted by the relative absence of cells in S-phase.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b3832185-1cdc-460a-a0a5-45d3b407e3d8","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3832185-1cdc-460a-a0a5-45d3b407e3d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30322869","allele":{"id":"https://genegraph.clinicalgenome.org/r/90c7abac-0ad2-40d9-943b-01796836c6d0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.740G>C (p.Gly247Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368201194"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7a5684a0-8b58-4863-85bc-3809ec17721b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a5684a0-8b58-4863-85bc-3809ec17721b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29146900","allele":{"id":"https://genegraph.clinicalgenome.org/r/85fe0231-46f6-4287-943f-90356c6ba088","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.3538T>C (p.Trp1180Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368181803"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/7a5684a0-8b58-4863-85bc-3809ec17721b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"EdU incorporation assay showed that GOF SAMD9L variants inhibit cells from progressing through the cell cycle as depicted by the relative absence of cells in S-phase.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2b279c64-3eb1-4625-9a9b-1be8b6500bbc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b279c64-3eb1-4625-9a9b-1be8b6500bbc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28202457","allele":{"id":"https://genegraph.clinicalgenome.org/r/2059f9dd-f4da-4a08-ab26-de5fe19a7168","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.2956C>T (p.Arg986Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368185911"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/2b279c64-3eb1-4625-9a9b-1be8b6500bbc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant has a lower proliferation rate than WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ed36aaa8-1129-4113-995b-d14d9730faa1","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed36aaa8-1129-4113-995b-d14d9730faa1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30322869","allele":{"id":"https://genegraph.clinicalgenome.org/r/c767288f-12b7-4585-b941-792953388cb4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.149T>C (p.Leu50Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368206797"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/dc708ea8-052c-446d-8c43-67f024d28890","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc708ea8-052c-446d-8c43-67f024d28890_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30322869","allele":{"id":"https://genegraph.clinicalgenome.org/r/5394ec46-7fef-4681-9209-dbc0d4f170e5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.2182T>C (p.Ser728Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4343624"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/310c03d6-a9f7-4971-9f95-85c423fe7d15","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/310c03d6-a9f7-4971-9f95-85c423fe7d15_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37216690","allele":{"id":"https://genegraph.clinicalgenome.org/r/a646c92e-c227-431f-9198-3b117ed30e10","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.190C>G (p.Pro64Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368206707"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/74e2b40f-7872-4b02-a88a-bf81cb7b356f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74e2b40f-7872-4b02-a88a-bf81cb7b356f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34621053","allele":{"id":"https://genegraph.clinicalgenome.org/r/295a2484-a60b-4403-a0b8-56a193118c42","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.4537T>C (p.Trp1513Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368171058"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/74e2b40f-7872-4b02-a88a-bf81cb7b356f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Growth inhibition of HEK293 cells upon overexpression of SAMD9L variant constructs.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/60ff6a8e-d7ef-4619-be6d-abc28c1897fa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60ff6a8e-d7ef-4619-be6d-abc28c1897fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30322869","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c496ac4-4feb-4abd-997a-6a1be5a301da","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.703G>A (p.Gly235Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4343827"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/60ff6a8e-d7ef-4619-be6d-abc28c1897fa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant had a higher proliferation rate than WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4b94cac9-9baa-40d2-a9c5-23b1f3228e0b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b94cac9-9baa-40d2-a9c5-23b1f3228e0b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37216690","allele":{"id":"https://genegraph.clinicalgenome.org/r/1af005c2-9606-41e0-b524-b62645a88238","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.2494dup (p.Thr832AsnfsTer16)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA645555114"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bd745675-1d81-4087-8e7a-b96f4191f65d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd745675-1d81-4087-8e7a-b96f4191f65d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30322869","allele":{"id":"https://genegraph.clinicalgenome.org/r/e7b6917a-dc81-42ee-a18a-861488e08528","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.683G>A (p.Cys228Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368201608"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/bd745675-1d81-4087-8e7a-b96f4191f65d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant had a higher proliferation rate than WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8aa83eac-6c20-488e-b7a8-1c487733d841","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8aa83eac-6c20-488e-b7a8-1c487733d841_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34621053","allele":{"id":"https://genegraph.clinicalgenome.org/r/32fd3bf0-23a5-41ff-9680-d1723e821e06","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.2308A>G (p.Lys770Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368191458"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/8aa83eac-6c20-488e-b7a8-1c487733d841_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Growth inhibition of HEK293 cells upon overexpression of SAMD9L variant constructs","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/475b84ba-86d7-442c-a942-8d5bb4e6039d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/475b84ba-86d7-442c-a942-8d5bb4e6039d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34621053","allele":{"id":"https://genegraph.clinicalgenome.org/r/140bfdf9-b028-411d-8fd2-20be307e49c1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152703.5(SAMD9L):c.2675T>G (p.Met892Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368186656"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/475b84ba-86d7-442c-a942-8d5bb4e6039d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Growth inhibition of HEK293 cells upon overexpression of SAMD9L variant constructs","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/1b553726-ca22-4116-bb50-373089ac4cb6_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b553726-ca22-4116-bb50-373089ac4cb6_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a540abff-4965-44e1-a6ac-dc44add4ef6c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90c234d5-7d30-4ea5-aacd-99967d49f719","type":"Finding","dc:description":"Immunostaining with anti-SAMD9L antibody in control cerebellar sections revealed a punctate staining mainly in Purkinje cell soma in the human cerebellar cortex and multipolar neurons of the cerebellar dentate nucleus, similar to mitochondrial ATP5B protein staining, indicative of mitochondrial localization. SAMD9L staining was also examined in fibroblast cells from age-matched control and one affected patient, revealing mitochondrial staining and co-localization to the mitochondrial marker mitoTracker Red CMXRos.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35310830","rdfs:label":"Corral-Juan expression","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1b553726-ca22-4116-bb50-373089ac4cb6_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90236978-c685-4046-a2e3-e290f0732346","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1259b7bd-5d7d-4d05-9897-d80f8adfec9e","type":"Finding","dc:description":"SAMD9L+/− and SAMD9L−/− mice developed myeloid dysplasia (8 of 15 SAMD9L−/−; 8 of 19 SAMD9L+/−), myeloid leukemia (1 of 15 SAMD9L−/−; 1 of 19 SAMD9L+/−), and myeloproliferative disease (1 of 19 SAMD9L+/−), which reflects the phenotypes that have been reported in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24029230","rdfs:label":"Nagamachi mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":10829,"specifiedBy":"GeneValidityCriteria11","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Ph4uCz2CQ8E","type":"GeneValidityProposition","disease":"obo:MONDO_1060111","gene":"hgnc:1349","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_1b553726-ca22-4116-bb50-373089ac4cb6-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}